tiprankstipranks
Rani Therapeutics price target raised to $14 from $7 at BTIG
PremiumThe FlyRani Therapeutics price target raised to $14 from $7 at BTIG
7d ago
Drugmakers work to make treatments to maintain weight loss, WSJ reports
PremiumThe Fly
Drugmakers work to make treatments to maintain weight loss, WSJ reports
8d ago
Lilly Declares Second-Quarter 2024 Dividend
PremiumPress Releases
Lilly Declares Second-Quarter 2024 Dividend
10d ago
Galderma Seizes Ozempic Face Opportunity
PremiumMarket NewsGalderma Seizes Ozempic Face Opportunity
15d ago
Eli Lilly price target raised to $875 from $825 at Wells Fargo
PremiumThe Fly
Eli Lilly price target raised to $875 from $825 at Wells Fargo
15d ago
Eli Lilly price target raised to $913 from $810 at Barclays
PremiumThe Fly
Eli Lilly price target raised to $913 from $810 at Barclays
15d ago
Eli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
PremiumThe FlyEli Lilly raises FY24 adjusted EPS view to $13.50-$14.00 from $12.20-$12.70
16d ago
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
PremiumThe Fly
Eli Lilly reports Q1 EPS $2.58, consensus $2.46
16d ago
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
PremiumPress Releases
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100